BHC 📈 Bausch Health Companies - Overview

Bausch Health Companies Inc. is a multinational corporation that operates in the pharmaceutical and medical device sectors, with a diverse portfolio of products that cater to various therapeutic areas, including gastroenterology, hepatology, neurology, dermatology, and eye health. The company's product range encompasses prescription and over-the-counter medications, as well as medical devices, which are developed, manufactured, and marketed globally. Its business is organized into five distinct segments, each focusing on specific areas of expertise: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.

The Salix segment is dedicated to the development and commercialization of gastroenterology products in the United States, addressing conditions such as irritable bowel syndrome and inflammatory bowel disease. In contrast, the International segment has a broader scope, selling a range of products, including aesthetic medical devices, branded and generic pharmaceuticals, and over-the-counter products, across international markets. The Solta Medical segment is focused on the sale of aesthetic medical devices, which are used in cosmetic procedures to improve skin appearance and reduce signs of aging. The Diversified segment offers a diverse range of pharmaceutical products, including those for neurology, ortho dermatologic, and dentistry applications in the United States.

The Bausch + Lomb segment is a leading provider of eye health products, including vision care, surgical, and ophthalmic pharmaceuticals. This segment develops and markets a range of products, from contact lenses and lens care products to surgical equipment and pharmaceuticals for eye diseases. With a rich history dating back to 1853, Bausch + Lomb has established itself as a trusted brand in the eye health industry. Following a significant transformation, the company formerly known as Valeant Pharmaceuticals International, Inc. changed its name to Bausch Health Companies Inc. in July 2018, marking a new chapter in its history. Headquartered in Laval, Canada, Bausch Health Companies Inc. is a publicly traded company, listed on the New York Stock Exchange under the ticker symbol BHC.

As a global healthcare company, Bausch Health Companies Inc. is committed to improving the lives of patients worldwide. With a strong presence in the pharmaceutical and medical device industries, the company continues to invest in research and development, expanding its portfolio of products and technologies to address unmet medical needs. Through its five business segments, Bausch Health Companies Inc. provides a wide range of innovative products and solutions, from pharmaceuticals and medical devices to over-the-counter products and eye health solutions. With its diverse portfolio and global reach, the company is well-positioned to drive growth and deliver value to its stakeholders, including patients, customers, and investors.